HK1207007A1 - Method of treatment of wrinkles using topical chemodenervating agents - Google Patents

Method of treatment of wrinkles using topical chemodenervating agents Download PDF

Info

Publication number
HK1207007A1
HK1207007A1 HK15107806.2A HK15107806A HK1207007A1 HK 1207007 A1 HK1207007 A1 HK 1207007A1 HK 15107806 A HK15107806 A HK 15107806A HK 1207007 A1 HK1207007 A1 HK 1207007A1
Authority
HK
Hong Kong
Prior art keywords
wrinkles
treatment
methods
chemodenervating agents
agents
Prior art date
Application number
HK15107806.2A
Other languages
English (en)
Chinese (zh)
Inventor
Jacob Waugh
L. Daniel Browne
Original Assignee
Revance Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revance Therapeutics, Inc. filed Critical Revance Therapeutics, Inc.
Publication of HK1207007A1 publication Critical patent/HK1207007A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Biotechnology (AREA)
HK15107806.2A 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents HK1207007A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614206P 2012-03-22 2012-03-22
US61/614,206 2012-03-22
PCT/US2013/033417 WO2013142755A1 (en) 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents

Publications (1)

Publication Number Publication Date
HK1207007A1 true HK1207007A1 (en) 2016-01-22

Family

ID=49212026

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107806.2A HK1207007A1 (en) 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents

Country Status (11)

Country Link
US (2) US20130251770A1 (enExample)
EP (2) EP3103472A1 (enExample)
JP (1) JP2015514074A (enExample)
KR (1) KR20140139010A (enExample)
CN (1) CN104602703A (enExample)
AU (1) AU2013234988A1 (enExample)
BR (1) BR112014023244A2 (enExample)
CA (1) CA2867511A1 (enExample)
HK (1) HK1207007A1 (enExample)
MX (1) MX2014011376A (enExample)
WO (1) WO2013142755A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP3760186A1 (en) * 2014-04-30 2021-01-06 Allergan, Inc. Formulations of biologics for intravesical instillation
CN109069608A (zh) 2015-10-29 2018-12-21 雷文斯治疗公司 具有长的治疗或美容效应持续时间的可注射肉毒杆菌毒素制剂以及其使用方法
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
WO2020069222A1 (en) * 2018-09-26 2020-04-02 Global Health Solutions Llc Topical neurotoxin compositions
KR20200080179A (ko) 2018-12-26 2020-07-06 아미코젠주식회사 아세틸콜린 수용체 저해 펩타이드 및 이의 용도
EP4393502A2 (en) 2018-12-26 2024-07-03 Skinmed Co., Ltd. Acetylcholine receptor inhibitory peptides and uses thereof
KR20230017747A (ko) 2021-07-27 2023-02-06 주식회사 스킨메드 아세틸콜린 수용체 결합 최적화 단축 펩타이드 및 이의 용도
EP4378950A4 (en) 2021-07-27 2025-10-15 Skinmed Co Ltd OPTIMIZED SHORTENED PEPTIDE THAT BINDS TO THE ACETYLCHOLINE RECEPTOR, AND ITS USE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5632731A (en) * 1994-11-25 1997-05-27 The Kendall Company Non-adherent wound dressing
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
HUE025656T2 (en) * 2004-03-03 2016-04-28 Revance Therapeutics Inc Topical application and transdermal delivery of botulinum toxins
BRPI0508440A (pt) * 2004-03-03 2007-07-24 Revance Therapeutics Inc composições e métodos para diagnóstico tópico e transporte terapêutico
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
JP2005306746A (ja) * 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
EP1796676B1 (en) * 2004-05-07 2016-03-09 Phytotox Limited Transdermal administration of phycotoxins
US7838011B2 (en) 2005-02-14 2010-11-23 Pankaj Modi Stabilized protein compositions for topical administration and methods of making same
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
WO2007059528A2 (en) 2005-11-17 2007-05-24 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
PL3144013T3 (pl) 2005-12-01 2019-04-30 Univ Of Massachusetts Lowell Nanoemulsje botulinowe
WO2008082889A2 (en) * 2006-12-29 2008-07-10 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat
US20100050075A1 (en) 2008-08-22 2010-02-25 Lennox Manufacturing, Inc., A Corporation Of Delaware Display apparatus and method for a control unit for an environmental control system
CN102869373B (zh) 2009-06-25 2017-05-10 雷文斯治疗公司 不含白蛋白的肉毒杆菌毒素制剂
BR112012010058A2 (pt) * 2009-10-30 2016-05-31 Duoject Inc aplicador tópico para um agente paralítico e método para aplicação do agente
ES3036435T3 (en) * 2011-01-07 2025-09-18 Revance Therapeutics Inc Kits for topical application, removal, and inactivation of therapeutic or cosmetic botulinum toxin compositions

Also Published As

Publication number Publication date
WO2013142755A1 (en) 2013-09-26
KR20140139010A (ko) 2014-12-04
CA2867511A1 (en) 2013-09-26
US20130251770A1 (en) 2013-09-26
EP2841095A1 (en) 2015-03-04
MX2014011376A (es) 2014-10-14
AU2013234988A1 (en) 2014-10-09
CN104602703A (zh) 2015-05-06
EP3103472A1 (en) 2016-12-14
US20170157020A1 (en) 2017-06-08
EP2841095A4 (en) 2016-01-13
JP2015514074A (ja) 2015-05-18
BR112014023244A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
WO2013158851A3 (en) Improving skin appearance with increase in skin chroma
HK1203356A1 (en) Pharmaceutical combinations comprising a thionucleotide analog
MX2015005722A (es) Composiciones y metodos para el tratamiento de proteinopatias.
BR112014023244A2 (pt) método de tratamento de rugas usando agentes quimiodesenervantes tópicos
WO2011143171A3 (en) Compositions containing dna repair enzyme and anogeissus extract
WO2012050745A3 (en) Compositions containing zinc pca and anogeissus extract
WO2014093078A3 (en) Cosmetic compositions with near infrared (nir) light - emitting material and methods therefor
BR112015014497A2 (pt) composição cosmética, método para aprimorar a característica de pele e utilização da composição.
WO2013160338A3 (en) Topical spray composition and system for delivering the same
IL251543B (en) Use of gel compounds in the production of medicine to prevent or treat skin diseases
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
BRPI0918352A2 (pt) composição cosmética antiperspirante, processo para a fabricação de uma composição e método de assentuar visualmente a aparência da pele e simultaneamente reduzir a perspiração em uma região localizada da pele
IN2014DE01913A (enExample)
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
EP3011963A4 (en) Composition comprising filler and botulinum toxin for alleviating skin wrinkles or aging or treating neuromuscular diseases
WO2012128971A3 (en) Topical acyl glutathione formulations
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
EP2730585A4 (en) PROTEIN-PEPTIDE COMPLEX HAVING SPECIFIC ACTION ON DERMAL TISSUES, PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
WO2014039340A3 (en) A method for the permanent removal of hair
PT2793946T (pt) Composição tópica filmogénica e uso da mesma para tratar ou prevenir a onicofagia
WO2014053625A3 (fr) Propionibacterium freudenreichii en tant qu'actif contre les désordres cutanés
MX2014003127A (es) Metodo para evaluar la reduccion de transpiracion.
WO2013092077A3 (de) Verformungsmittel für keratinische fasern und haarverformungsverfahren